Please use this identifier to cite or link to this item: doi:10.22028/D291-47820
Title: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers
Author(s): Schnellhardt, Sören
Böke, Simon
Tribius, Silke
Krause, Mechthild
Haderlein, Marlen
Rühle, Alexander
Süß, Christoph
Linge, Annett
Hecht, Markus
Balermpas, Panagiotis
Language: English
Publisher/Platform: Springer Nature
Year of Publication: 2026
DDC notations: 610 Medicine and health
Publikation type: Other
DOI of the first publication: 10.1007/s00066-026-02511-6
URL of the first publication: https://link.springer.com/article/10.1007/s00066-026-02511-6
Link to this record: urn:nbn:de:bsz:291--ds-478205
hdl:20.500.11880/41819
http://dx.doi.org/10.22028/D291-47820
Date of registration: 12-May-2026
Notes: Strahlentherapie und Onkologie, 2026, 202, 359-361
Faculty: M - Medizinische Fakultät
Department: M - Radiologie
Professorship: M - Prof. Dr. Markus Hecht
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s00066-026-02511-6.pdf145,26 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons